Testing a new platform to screen disease-modifying therapy in type 1 diabetes

Testing a new platform to screen disease-modifying therapy in type 1 diabetes

Bibliographic Details
Main Authors:	Sandra M. Lord, Henry T. Bahnson, Carla J. Greenbaum, David R. Liljenquist, John Virostko, Cate Speake
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721089/?tool=EBI

Similar Items

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes
by: Alyssa Ylescupidez, et al.
Published: (2023-11-01)

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study
by: Cate Speake, et al.
Published: (2019-09-01)

Insulin is necessary but not sufficient: changing the therapeutic paradigm in type 1 diabetes [version 1; peer review: 5 approved]
by: Sandra Lord, et al.
Published: (2020-07-01)

Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation
by: Cate Speake, et al.
Published: (2015-09-01)

Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation
by: Cate Speake, et al.
Published: (2015-01-01)

Quantitative Magnetic Resonance Imaging of the Pancreas of Individuals With Diabetes
by: John Virostko, et al.
Published: (2020-12-01)

Characterizing T cell responses to enzymatically modified beta cell neo-epitopes
by: Hai Nguyen, et al.
Published: (2023-01-01)

Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes
by: Jeremy R. B. Newman, et al.
Published: (2023-09-01)

The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types.
by: Peter S Linsley, et al.
Published: (2015-01-01)

Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes
by: Elisa Balmas, et al.
Published: (2023-11-01)

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review
by: Jamie L. Felton, et al.
Published: (2023-10-01)

Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.
by: John Virostko, et al.
Published: (2016-01-01)

IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function
by: Cate Speake, et al.
Published: (2022-11-01)

Book Wars Review
by: Rosie Liljenquist
Published: (2022-06-01)

Testing Screened Modified Gravity
by: Philippe Brax, et al.
Published: (2021-12-01)

Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes
by: Peter S. Linsley, et al.
Published: (2021-11-01)

Citrullination of glucokinase is linked to autoimmune diabetes
by: Mei-Ling Yang, et al.
Published: (2022-04-01)

Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies
by: Samuel D. Klebanoff, et al.
Published: (2023-08-01)

A mobile platform for non-invasive diabetes screening
by: Chauhan, Shivani,M. Eng.Massachusetts Institute of Technology.
Published: (2020)

Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosis.
by: Peter S Linsley, et al.
Published: (2014-01-01)

Deep learning-based pancreas volume assessment in individuals with type 1 diabetes
by: Raphael Roger, et al.
Published: (2022-01-01)

An Electrochemical Aptasensor Platform Based on Flower-Like Gold Microstructure-Modified Screen-Printed Carbon Electrode for Detection of Serpin A12 as a Type 2 Diabetes Biomarker
by: Salek Maghsoudi A, et al.
Published: (2020-03-01)

Recommendations for Screening and Monitoring the Stages of Type 1 Diabetes in the Immune Therapy Era
by: Moore DJ, et al.
Published: (2024-07-01)

Performance of diabetes screening tests: an evaluation study of Iranian diabetes screening program
by: Fateme Kianpour, et al.
Published: (2021-01-01)

Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
by: Alexander J. O’Donovan, et al.
Published: (2024-11-01)

Autonomic test by EZSCAN in the screening for prediabetes and diabetes.
by: Zhi Yang, et al.
Published: (2013-01-01)

Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions
by: Greenhalgh, T, et al.
Published: (2017)

Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.
by: Barry, E, et al.
Published: (2017)

Dendrimer-modified gold nanorods as a platform for combinational gene therapy and photothermal therapy of tumors
by: Lili Ye, et al.
Published: (2021-09-01)

Novel electrochemical sensing platform for detection of hydrazine based on modified screen-printed graphite electrode
by: Farideh Mousazadeh, et al.
Published: (2022-10-01)

Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
by: Alexander J. O’Donovan, et al.
Published: (2025-01-01)

Non-invasive management of primary phosphodiesterase type 5 inhibitor failure in patients with erectile dysfunction
by: Gregory Lowe MD, et al.
Published: (2009-12-01)

Role of standard test meal in initiation of insulin therapy in type 2 diabetes
by: Koprivica Branka, et al.
Published: (2009-01-01)

Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes
by: Yu-Chuan Huang, et al.
Published: (2023-03-01)

Determination of Prevalence of Type 2 Diabetes Mellitus by Screening Tests using a Mathematical Formula in Place of Invasive Blood Tests
by: Neeru Gupta, et al.
Published: (2016-01-01)

Neuropsychiatric screening in type 2 diabetes mellitus
by: Sunil K Kota, et al.
Published: (2012-01-01)

Screening for type 2 diabetes: literature review and economic modelling
by: N Waugh, et al.
Published: (2007-05-01)

Quality of Mobile Apps for Child Development Support: Search in App Stores and Content Analysis
by: Akeiylah DeWitt, et al.
Published: (2022-11-01)

Modified Hodge test as screening test for spreading Carbapenemase resistance has become more important
by: Mustafa Hatipoglu, et al.
Published: (2013-01-01)

Diagnostic Accuracy of Screening Tests for Diabetic Peripheral Neuropathy: An Umbrella Review
by: María Mogilevskaya, et al.
Published: (2024-01-01)